Beckman Coulter strengthens immunoassay business with "savvy" DSL (Diagnostic Systems Laboratories) buy
This article was originally published in Clinica
Executive Summary
In a move that will see significant acceleration in its immunoassay business growth, Beckman Coulter is to acquire Diagnostic Systems Laboratories (DSL), a private Webster, Texas-based developer of specialty endocrinology tests, for $138m including debt. The deal is expected to close in mid-October.